한글목차

방광암 검출 키트 동향과 예측

세계의 방광암 검출 키트 시장 규모는 2024년부터 2030년까지 CAGR 11.8%로 성장하여 2030년까지 약 4억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 성장 촉진요인은 방광암 유병률 증가, 헬스케어 비용 급등, 담배 소비량 증가입니다. 세계의 방광암 검출 키트 시장의 미래는 병원·진료소 및 진단 센터 시장에서의 기회에 의해 유망해 보입니다.

방광암 검출 키트 시장 인사이트

Lucintel은 FISH(Fluorescent In Situ Hybridization)가 예측기간 동안 최대 부문으로 남을 것으로 예측하고 있습니다. 이 분야에서 사용되는 새로운 소변 검사 기술은 직접 표지 된 형광 DNA 프로브를 사용하고, 소변을 포함한 요로 상피 세포 유전자 이상을 조사하기 때문입니다.

이 시장에서는 세계의 병원 인프라 진보에 의해 병원·진료소가 최대 부문으로 남을 것으로 생각됩니다.

북미는 이 지역의 방광암 이환율 증가에 의해 예측기간 동안 최대 지역으로 남을 것입니다.

자주 묻는 질문

Q1. 시장 규모는?

A1. 세계의 방광암 검출 키트 시장은 2030년까지 약 4억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 예측은?

A2. 세계의 방광암 검출 키트 시장은 2024년부터 2030년까지 CAGR 11.8%로 성장할 것으로 예측됩니다.

Q3. 시장의 성장에 영향을 미치는 주요 성장 촉진요인은?

A3. 이 시장의 주요 성장 촉진요인은 방광암 유병률 증가, 헬스케어 비용 급등, 담배 소비량 증가입니다.

Q4. 시장의 주요 부문은?

A4. 방광암 검출 키트 시장 전망은 병원·진료소 시장이라고 진단 센터 시장의 기회에 의해 유망시 됩니다.

Q5. 시장의 주요 기업은?

A5. 주요 방광암 검출 키트 기업은 다음과 같습니다.

• Abbott Laboratories
• Xiamen Biotime Biotechnology
• Abingdon Health
• Ameritek
• Alfa Scientific Designs
• NanoEnTek
• Exact Sciences
• Hubei Jinjian Biology
• Nanjing Liming Bio-Products
• Diagnosis

Q6. 향후 최대가 되는 시장 부문은?

A6. Lucintel은 FISH(Fluorescent In Situ Hybridization)가 이 분야에서 사용되는 새로운 소변 검사 기술이 직접 표지된 형광 DNA 프로브를 사용하고, 소변을 포함한 요로 상피 세포 유전자 이상을 검사하기 때문에 예측기간 동안 최대 부문으로 남을 것으로 예측하고 있습니다.

Q7. 시장에서 향후 5년 동안 최대가 될 것으로 예상되는 지역은?

A7. 북미에서는 방광암 발생률이 높아지고 있기 때문에 예측기간 중에도 최대 지역입니다.

Q8. 보고서 커스터마이징이 가능?

A8. 네, Lucintel은 추가 비용 없이 10% 커스터마이징이 가능합니다.

목차

제1장 주요 요약

제2장 세계의 방광암 검출 키트 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석 : 2018-2030년

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 방광암 검출 키트 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 방광암 검출 키트 시장 : 기술별
  • FISH(Fluorescent In Situ Hybridization)
  • 효소결합면역흡착 측정법
  • 기타
• 세계의 방광암 검출 키트 시장 : 최종 이용 산업별
  • 병원·진료소
  • 진단 센터
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2018-2030년)

• 세계의 방광암 검출 키트 시장 : 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 기술별
  • 최종 이용 산업별
  • 지역별
• 세계의 방광암 검출 키트 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 방광암 검출 키트 시장 능력 확대
  • 세계의 방광암 검출 키트 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Abbott Laboratories
• Xiamen Biotime Biotechnology
• Abingdon Health
• Ameritek
• Alfa Scientific Designs
• NanoEnTek
• Exact Sciences
• Hubei Jinjian Biology
• Nanjing Liming Bio-products
• Diagnosis

영문목차

Bladder Cancer Detective Kit Trends and Forecast

The future of the global bladder cancer detective kit market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets. The global bladder cancer detective kit market is expected to reach an estimated $0.4 billion by 2030 with a CAGR of 11.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of bladder cancer, escalating healthcare expenses, and the growing consumption of cigarettes and tobacco.

A more than 150-page report is developed to help in your business decisions.

Bladder Cancer Detective Kit by Segment

The study includes a forecast for the global bladder cancer detective kit by technology, end use industry, and region.

Bladder Cancer Detective Kit Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Fluorescence In Situ Hybridization
• Enzyme-Linked Immunosorbent Assay
• Others

Bladder Cancer Detective Kit Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers
• Others

Bladder Cancer Detective Kit Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Bladder Cancer Detective Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bladder cancer detective kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bladder cancer detective kit companies profiled in this report include-

• Abbott Laboratories
• Xiamen Biotime Biotechnology
• Abingdon Health
• Ameritek
• Alfa Scientific Designs
• NanoEnTek
• Exact Sciences
• Hubei Jinjian Biology
• Nanjing Liming Bio-Products
• Diagnosis

Bladder Cancer Detective Kit Market Insights

Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to novel urine testing technique used in this field looks for genetic abnormalities in pee-containing urothelial cells by using fluorescent DNA probes that have been directly labeled.

Within this market, hospitals & clinics will remain the largest segment due to advancements in hospital infrastructure worldwide.

North America will remain the largest region over the forecast period due to growing incidence of bladder cancer in the area.

Features of the Global Bladder Cancer Detective Kit Market

Market Size Estimates: Bladder cancer detective kit market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bladder cancer detective kit market size by technology, end use industry, and region in terms of value ($B).

Regional Analysis: Bladder cancer detective kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, end use industry, and regions for the bladder cancer detective kit market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bladder cancer detective kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the bladder cancer detective kit market size?

Answer: The global bladder cancer detective kit market is expected to reach an estimated $0.4 billion by 2030.

Q2. What is the growth forecast for bladder cancer detective kit market?

Answer: The global bladder cancer detective kit market is expected to grow with a CAGR of 11.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bladder cancer detective kit market?

Answer: The major drivers for this market are increasing prevalence of bladder cancer, escalating healthcare expenses, and the growing consumption of cigarettes and tobacco.

Q4. What are the major segments for bladder cancer detective kit market?

Answer: The future of the bladder cancer detective kit market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets.

Q5. Who are the key bladder cancer detective kit market companies?

Answer: Some of the key bladder cancer detective kit companies are as follows.

• Abbott Laboratories
• Xiamen Biotime Biotechnology
• Abingdon Health
• Ameritek
• Alfa Scientific Designs
• NanoEnTek
• Exact Sciences
• Hubei Jinjian Biology
• Nanjing Liming Bio-Products
• Diagnosis

Q6. Which bladder cancer detective kit market segment will be the largest in future?

Answer: Lucintel forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to novel urine testing technique used in this field looks for genetic abnormalities in pee-containing urothelial cells by using fluorescent DNA probes that have been directly labeled.

Q7. In bladder cancer detective kit market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing incidence of bladder cancer in the area.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bladder cancer detective kit market by technology (fluorescence in situ hybridization, enzyme-linked immunosorbent assay, and others), end use industry (hospitals & clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bladder Cancer Detective Kit Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Bladder Cancer Detective Kit Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Bladder Cancer Detective Kit Market by Technology
  • 3.3.1: Fluorescence In Situ Hybridization
  • 3.3.2: Enzyme-Linked Immunosorbent Assay
  • 3.3.3: Others
• 3.4: Global Bladder Cancer Detective Kit Market by End Use Industry
  • 3.4.1: Hospitals & Clinics
  • 3.4.2: Diagnostic Centers
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Bladder Cancer Detective Kit Market by Region
• 4.2: North American Bladder Cancer Detective Kit Market
  • 4.2.2: North American Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.3: European Bladder Cancer Detective Kit Market
  • 4.3.1: European Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
  • 4.3.2: European Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.4: APAC Bladder Cancer Detective Kit Market
  • 4.4.1: APAC Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
  • 4.4.2: APAC Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.5: ROW Bladder Cancer Detective Kit Market
  • 4.5.1: ROW Bladder Cancer Detective Kit Market by Technology: Fluorescence In Situ Hybridization, Enzyme-Linked Immunosorbent Assay, and Others
  • 4.5.2: ROW Bladder Cancer Detective Kit Market by End Use Industry: Hospitals & Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by Technology
  • 6.1.2: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by End Use Industry
  • 6.1.3: Growth Opportunities for the Global Bladder Cancer Detective Kit Market by Region
• 6.2: Emerging Trends in the Global Bladder Cancer Detective Kit Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bladder Cancer Detective Kit Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bladder Cancer Detective Kit Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Xiamen Biotime Biotechnology
• 7.3: Abingdon Health
• 7.4: Ameritek
• 7.5: Alfa Scientific Designs
• 7.6: NanoEnTek
• 7.7: Exact Sciences
• 7.8: Hubei Jinjian Biology
• 7.9: Nanjing Liming Bio-products
• 7.10: Diagnosis